FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to medicinal forms containing cytokines. An antiviral, antibacterial and anticandidosis agent comprises cytokines, stabilizing agent of resistance against bacterial contamination, glycerol and special additions. Agent can comprise additionally the following components: antioxidant, immunomodulating agent, antibacterial or protozoicide or antifungal agent, vitamins, anti-inflammatory preparation, topical anesthetic, riboxin. EFFECT: expanded assortment of agents with antiviral, antibacterial and anticandidosis effect. 21 cl, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CURATIVE AGENT | 2000 |
|
RU2187332C1 |
| CONDOM LUBRICANT | 2000 |
|
RU2187329C1 |
| ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
| MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
| MEDICINAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES | 2001 |
|
RU2185840C1 |
| ANTIVIRUS MEANS IN LIPOSOME FORM | 2000 |
|
RU2176518C1 |
| DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
| ANTIVIRAL MEDICATION - NASAL DROPS | 2010 |
|
RU2437676C1 |
| MEDICATION FOR VAGINAL APPLICATION, POSSESSING CONTRACEPTIVE AND PROTECTIVE AGAINST INFECTIOUS DISEASES ACTION | 2010 |
|
RU2432961C1 |
| INTRANASAL AGENT | 2002 |
|
RU2220739C1 |
